GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (FRA:X90) » Definitions » ROCE %

Probiotix Health (FRA:X90) ROCE % : -51.92% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Probiotix Health's annualized ROCE % for the quarter that ended in Jun. 2023 was -51.92%.


Probiotix Health ROCE % Historical Data

The historical data trend for Probiotix Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health ROCE % Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
ROCE %
- -85.92 4.90 -

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
ROCE % Get a 7-Day Free Trial 33.57 18.42 -23.02 - -51.92

Probiotix Health ROCE % Calculation

Probiotix Health's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2020 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2020 )(A: Dec. 2022 )
=0/( ( (0.977 - 0) + (2.693 - 0.313) )/ 2 )
=0/( (0.977+2.38)/ 2 )
=0/1.6785
=0.00 %

Probiotix Health's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=-1.194/( ( (2.693 - 0.313) + (2.896 - 0.677) )/ 2 )
=-1.194/( ( 2.38 + 2.219 )/ 2 )
=-1.194/2.2995
=-51.92 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Probiotix Health  (FRA:X90) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Probiotix Health ROCE % Related Terms

Thank you for viewing the detailed overview of Probiotix Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Probiotix Health (FRA:X90) Business Description

Traded in Other Exchanges
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (FRA:X90) Headlines

No Headlines